200 related articles for article (PubMed ID: 18191201)
21. Pentostatin in chronic lymphocytic leukemia.
Sauter C; Lamanna N; Weiss MA
Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1217-22. PubMed ID: 18721115
[TBL] [Abstract][Full Text] [Related]
22. Emerging therapies for patients with advanced chronic lymphocytic leukaemia.
Delgado J; Briones J; Sierra J
Blood Rev; 2009 Sep; 23(5):217-24. PubMed ID: 19643519
[TBL] [Abstract][Full Text] [Related]
23. Recent advances in chronic lymphocytic leukemia.
Abbott BL
Cancer Invest; 2006; 24(3):302-9. PubMed ID: 16809159
[TBL] [Abstract][Full Text] [Related]
24. Initial therapy for patients with chronic lymphocytic leukemia.
Wierda WG; O'Brien SM
Semin Oncol; 2006 Apr; 33(2):202-9. PubMed ID: 16616067
[TBL] [Abstract][Full Text] [Related]
25. Chemoimmunotherapy with low-dose fludarabine and cyclophosphamide and high dose rituximab in previously untreated patients with chronic lymphocytic leukemia.
Foon KA; Boyiadzis M; Land SR; Marks S; Raptis A; Pietragallo L; Meisner D; Laman A; Sulecki M; Butchko A; Schaefer P; Lenzer D; Tarhini A
J Clin Oncol; 2009 Feb; 27(4):498-503. PubMed ID: 19075274
[TBL] [Abstract][Full Text] [Related]
26. Chronic lymphocytic leukemia in the young patient.
de Lima M; O'Brien S; Lerner S; Keating MJ
Semin Oncol; 1998 Feb; 25(1):107-16. PubMed ID: 9482532
[TBL] [Abstract][Full Text] [Related]
27. High dose methylprednisolone and rituximab is an effective therapy in advanced refractory chronic lymphocytic leukemia resistant to fludarabine therapy.
Dungarwalla M; Evans SO; Riley U; Catovsky D; Dearden CE; Matutes E
Haematologica; 2008 Mar; 93(3):475-6. PubMed ID: 18310545
[TBL] [Abstract][Full Text] [Related]
28. Treatment of relapsed chronic lymphocytic leukemia: old and new therapies.
Byrd JC; Lin TS; Grever MR
Semin Oncol; 2006 Apr; 33(2):210-9. PubMed ID: 16616068
[TBL] [Abstract][Full Text] [Related]
29. Novel agents and strategies for treatment of p53-defective chronic lymphocytic leukemia.
Grever MR; Lucas DM; Johnson AJ; Byrd JC
Best Pract Res Clin Haematol; 2007 Sep; 20(3):545-56. PubMed ID: 17707839
[TBL] [Abstract][Full Text] [Related]
30. Management of chronic lymphocytic leukemia: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
Brugiatelli M; Bandini G; Barosi G; Lauria F; Liso V; Marchetti M; Mauro FR; Meloni G; Zinzani PL; Tura S; ; ;
Haematologica; 2006 Dec; 91(12):1662-73. PubMed ID: 17145603
[TBL] [Abstract][Full Text] [Related]
31. Rituximab, fludarabine, cyclophosphamide, and mitoxantrone: a new, highly active chemoimmunotherapy regimen for chronic lymphocytic leukemia.
Bosch F; Abrisqueta P; Villamor N; Terol MJ; González-Barca E; Ferra C; González Diaz M; Abella E; Delgado J; Carbonell F; García Marco JA; Escoda L; Ferrer S; Monzó E; González Y; Estany C; Jarque I; Salamero O; Muntañola A; Montserrat E
J Clin Oncol; 2009 Sep; 27(27):4578-84. PubMed ID: 19704063
[TBL] [Abstract][Full Text] [Related]
32. Current approach to diagnosis and management of chronic lymphocytic leukemia.
Shanafelt TD; Call TG
Mayo Clin Proc; 2004 Mar; 79(3):388-98. PubMed ID: 15008611
[TBL] [Abstract][Full Text] [Related]
33. Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells.
Bouzar AB; Boxus M; Defoiche J; Berchem G; Macallan D; Pettengell R; Willis F; Burny A; Lagneaux L; Bron D; Chatelain B; Chatelain C; Willems L
Br J Haematol; 2009 Jan; 144(1):41-52. PubMed ID: 19006566
[TBL] [Abstract][Full Text] [Related]
34. Current guidelines in defining therapeutic strategies.
Ferrajoli A; Keating MJ
Hematol Oncol Clin North Am; 2004 Aug; 18(4):881-93, ix. PubMed ID: 15325704
[TBL] [Abstract][Full Text] [Related]
35. Chronic lymphocytic leukemia.
Ghia P; Ferreri AM; Caligaris-Cappio F
Crit Rev Oncol Hematol; 2007 Dec; 64(3):234-46. PubMed ID: 17544290
[TBL] [Abstract][Full Text] [Related]
36. Chronic lymphocytic leukemia: diagnosis and treatment.
Yee KW; O'Brien SM
Mayo Clin Proc; 2006 Aug; 81(8):1105-29. PubMed ID: 16901035
[TBL] [Abstract][Full Text] [Related]
37. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
38. Waldenström's macroglobulinemia: prognostic factors and recent therapeutic advances.
Leblond V; Tournilhac O; Morel P
Clin Exp Med; 2004 Apr; 3(4):187-98. PubMed ID: 15103509
[TBL] [Abstract][Full Text] [Related]
39. In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
Lindhagen E; Norberg M; Kanduri M; Tobin G; Säisänen L; Aberg M; Gustafsson MG; Sundström C; Rosenquist R; Aleskog A
Eur J Haematol; 2009 Jul; 83(1):22-34. PubMed ID: 19245531
[TBL] [Abstract][Full Text] [Related]
40. Adding fresh frozen plasma to rituximab for the treatment of patients with refractory advanced CLL.
Klepfish A; Rachmilewitz EA; Kotsianidis I; Patchenko P; Schattner A
QJM; 2008 Sep; 101(9):737-40. PubMed ID: 18650226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]